After learning of her breast cancer recurrence, virologist Beata Halassy undertook an experimental self-treatment using oncolytic virotherapy, resulting in tumor shrinkage and ultimately surgery.
Despite skepticism from peers, the treatment involved a blend of measles and vesicular stomatitis virus, successfully eliciting an immune response that contributed to Halassy's recovery.
Halassy's journey reflects the challenges of self-experimentation and struggle for acceptance in the scientific community, despite her ultimately successful outcome.
Raised ethical questions about self-experimentation were a barrier in publishing her findings, revealing a tension between experimental innovation and professional standards.
Collection
[
|
...
]